Progenics Pharmaceuticals (NASDAQ:PGNX) Earnings Information
Progenics Pharmaceuticals last issued its earnings data on November 7th, 2019. The biotechnology company reported ($0.22) earnings per share for the quarter, topping analysts' consensus estimates of ($0.24) by $0.02. The business had revenue of $5.61 million for the quarter, compared to the consensus estimate of $7.05 million. Progenics Pharmaceuticals has generated ($0.63) earnings per share over the last year. Progenics Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 12th, 2020 based off prior year's report dates.
Progenics Pharmaceuticals Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
Progenics Pharmaceuticals (NASDAQ PGNX) Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | GAAP EPS | Revenue Estimate | Actual Revenue | Conference Call | Details |
|---|
3/12/2020
(Estimated) | | | | | | | | |
| 11/7/2019 | Q3 | ($0.2440) | ($0.22) | ($0.22) | $7.05 million | $5.61 million | N/A | |
| 8/9/2019 | Q2 | ($0.21) | ($0.23) | ($0.23) | $6.40 million | $9.97 million | N/A | |
| 5/9/2019 | Q1 | ($0.24) | ($0.22) | ($0.22) | $3.71 million | $4.28 million | N/A | |
| 3/14/2019 | Q4 | ($0.03) | ($0.17) | ($0.17) | $10.99 million | $3.24 million | N/A | |
| 11/8/2018 | Q3 | ($0.18) | ($0.09) | $0.12 | $4.14 million | $5.32 million | N/A | |
| 7/31/2018 | Q2 2018 | ($0.1840) | ($0.20) | ($0.20) | $3.30 million | $3.88 million | N/A | |
| 5/9/2018 | Q1 2018 | ($0.23) | ($0.19) | ($0.19) | $4.10 million | $3.19 million | N/A | |
| 3/8/2018 | Q4 2017 | ($0.21) | ($0.21) | ($0.38) | $3.18 million | $3.90 million | N/A | |
| 11/2/2017 | Q3 2017 | ($0.24) | ($0.22) | ($0.22) | $3.58 million | $2.70 million | N/A | |
| 8/9/2017 | Q2 2017 | ($0.20) | ($0.24) | ($0.24) | $3.34 million | $2.77 million | Listen | |
| 5/4/2017 | Q1 2017 | ($0.16) | ($0.23) | ($0.23) | $4.50 million | $2.40 million | Listen | |
| 3/9/2017 | Q4 2016 | ($0.22) | ($0.10) | ($0.10) | $4.43 million | $4.65 million | Listen | |
| 11/7/2016 | Q3 2016 | $0.51 | $0.52 | $0.52 | $52.90 million | $53.90 million | Listen | |
| 8/4/2016 | Q2 2016 | ($0.11) | ($0.08) | ($0.08) | $6.33 million | $8.50 million | N/A | |
| 5/5/2016 | Q1 2016 | ($0.12) | ($0.18) | ($0.18) | $3.27 million | $2.50 million | Listen | |
| 3/11/2016 | Q4 2015 | ($0.14) | ($0.10) | ($0.10) | $2.25 million | $5.10 million | Listen | |
| 11/9/2015 | Q3 2015 | ($0.12) | ($0.14) | ($0.14) | $2.35 million | $1.40 million | Listen | |
| 8/6/2015 | Q2 2015 | ($0.15) | ($0.17) | ($0.17) | $1.63 million | $1.90 million | Listen | |
| 5/6/2015 | Q1 2015 | ($0.16) | ($0.15) | ($0.15) | $1.30 million | $0.25 million | N/A | |
| 3/16/2015 | Q4 2014 | ($0.13) | ($0.18) | ($0.18) | $2.87 million | ($0.57) million | N/A | |
| 11/7/2014 | Q3 2014 | ($0.14) | $0.51 | $0.51 | $2.50 million | $41.66 million | N/A | |
| 8/8/2014 | Q2 2014 | ($0.11) | ($0.17) | ($0.17) | $2.83 million | $1.50 million | Listen | |
| 5/9/2014 | Q1 2014 | ($0.13) | ($0.15) | ($0.15) | $2.88 million | $1.80 million | N/A | |
| 3/13/2014 | Q4 | ($0.19) | ($0.14) | | $1.48 million | $3.00 million | Listen | |
| 3/3/2014 | Q4 2013 | ($0.19) | ($0.14) | ($0.14) | $1.74 million | $2.97 million | N/A | |
| 11/11/2013 | Q3 2013 | ($0.21) | ($0.17) | ($0.17) | $2.00 million | $0.90 million | N/A | |
| 8/9/2013 | Q2 2013 | ($0.25) | ($0.24) | ($0.24) | $1.86 million | $1.80 million | N/A | |
| 5/10/2013 | Q1 2013 | ($0.19) | ($0.22) | ($0.22) | $1.71 million | $2.23 million | Transcript | |
| 3/15/2013 | Q4 2012 | ($0.31) | ($0.01) | | $1.16 million | $8.87 million | N/A | |
| 11/8/2012 | Q312 | ($0.30) | ($0.33) | | $2.52 million | $1.10 million | N/A | |
| 8/9/2012 | | ($0.32) | ($0.32) | | | | N/A | |
| 5/8/2012 | | ($0.33) | ($0.39) | | | | N/A | |
| 3/15/2012 | Q4 2011 | ($0.25) | ($0.32) | ($0.32) | | | N/A | |
| 11/9/2011 | | ($0.33) | ($0.34) | | | | N/A | |
| 8/9/2011 | | ($0.25) | $1.64 | | | | Transcript | |
| 5/10/2011 | | ($0.51) | ($0.69) | | | | Transcript | |
| 3/15/2011 | | ($0.57) | ($0.57) | | | | Transcript | |
| 11/8/2010 | Q3 2010 | ($0.56) | ($0.52) | ($0.52) | | | N/A | |
| 8/9/2010 | Q2 2010 | ($0.54) | ($0.47) | ($0.47) | | | N/A | |
| 5/10/2010 | Q1 2010 | ($0.41) | ($0.58) | ($0.58) | | | N/A | |
| 3/15/2010 | Q4 2009 | ($0.14) | ($0.02) | ($0.02) | | | N/A | |
| 11/9/2009 | Q3 2009 | ($0.44) | ($0.41) | ($0.41) | | | N/A | |
| 8/6/2009 | Q2 2009 | ($0.50) | ($0.50) | ($0.51) | | | N/A | |
| 5/11/2009 | Q1 2009 | ($0.27) | ($0.06) | ($0.06) | | | N/A | |
| 3/13/2009 | Q4 2008 | ($0.30) | ($0.49) | ($0.49) | | | N/A | |
| 11/10/2008 | Q3 2008 | ($0.28) | ($0.41) | ($0.41) | | | N/A | |
| 8/8/2008 | Q2 2008 | $0.01 | ($0.08) | ($0.08) | | | N/A | |
| 5/9/2008 | Q1 2008 | ($0.41) | ($0.52) | ($0.52) | | | N/A | |
| 3/17/2008 | Q4 2007 | ($0.46) | ($0.53) | ($0.53) | | | N/A | |
(Earnings results data provided by Zacks Investment Research)
